“…In turn, recent work in our research group showed that some 4-thiazolidinone derivatives (b, Figure 1) obtained from formilpyridine thiosemicarbazones possess considerable antimicrobial activity against Micrococcus luteus, Mycobacterium phlei, Mycobacterium smegmatis, Mycobacterium tuberculosis, Malassezia furfur and Candida albicans. 7 On the other hand, Zhou et al 8 identified ten cytoselective compounds from 372 thiazolidinone analogues (c, Figure 1) by applying iterative library approaches. These compounds selectively killed both non-small cell lung cancer cell line H460 and its paclitaxel-resistant variant H460taxR at an IC 50 between 0.21 and 2.93 μM while showing much less toxicity to normal human fibroblasts at concentrations up to 195 μM.…”